T. Rowe Price Associates’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $126M | Buy |
|
|||||
|
2025
Q2 | $32.9M | Sell |
|
|||||
|
2025
Q1 | $58.5M | Sell |
|
|||||
|
2024
Q4 | $140M | Buy |
|
|||||
|
2024
Q3 | $123M | Buy |
|
|||||
|
2024
Q2 | $74.8M | Buy |
|
|||||
|
2024
Q1 | $6.2M | Sell |
|
|||||
|
2023
Q4 | $7.05M | Buy |
|
|||||
|
2023
Q3 | $5.5M | Sell |
|
|||||
|
2023
Q2 | $5.42M | Buy |
|
|||||
|
2023
Q1 | $5.4M | Buy |
|
|||||
|
2022
Q4 | $6.54M | Buy |
|
|||||
|
2022
Q3 | $4.78M | Sell |
|
|||||
|
2022
Q2 | $31.3M | Buy |
|
|||||
|
2022
Q1 | $10.6M | Buy |
|
|||||
|
2021
Q4 | $12.7M | Sell |
|
|||||
|
2021
Q3 | $11.1M | Sell |
|
|||||
|
2021
Q2 | $11M | Sell |
|
|||||
|
2021
Q1 | $59.2M | Buy |
|
|||||
|
2020
Q4 | $37M | Buy |
|
|||||
|
2020
Q3 | $3.28M | Sell |
|
|||||
|
2020
Q2 | $4.05M | Sell |
|
|||||
|
2020
Q1 | $24.2M | Buy |
|
|||||
|
2019
Q4 | $4.1M | Buy |
|
|||||
|
2019
Q3 | $3.31M | Buy |
|
|||||
|
2019
Q2 | $3.22M | Buy |
|
|||||
|
2019
Q1 | $4.84M | Buy |
|
|||||
|
2018
Q4 | $4.45M | Buy |
|
|||||
|
2018
Q3 | $5.21M | Sell |
|
|||||
|
2018
Q2 | $4.91M | Sell |
|
|||||
|
2018
Q1 | $14.8M | Sell |
|
|||||
|
2017
Q4 | $19.7M | Sell |
|
|||||
|
2017
Q3 | $21.2M | Buy |
|
|||||
|
2017
Q2 | $23M | Buy |
|
|||||
|
2017
Q1 | $23.2M | Sell |
|
|||||
|
2016
Q4 | $25.1M | Sell |
|
|||||
|
2016
Q3 | $21.5M | Buy |
|
|||||
|
2016
Q2 | $17.7M | Sell |
|
|||||
|
2016
Q1 | $19.1M | Buy |
|
|||||
|
2015
Q4 | $26.8M | Sell |
|
|||||
|
2015
Q3 | $98.9M | Sell |
|
|||||
|
2015
Q2 | $157M | Sell |
|
|||||
|
2015
Q1 | $161M | Sell |
|
|||||
|
2014
Q4 | $124M | Buy |
|
|||||
|
2014
Q3 | $110M | Buy |
|
|||||
|
2014
Q2 | $72M | Buy |
|
|||||
|
2014
Q1 | $75.7M | Buy |
|
|||||
|
2013
Q4 | $55.2M | Buy |
|
|||||
|
2013
Q3 | $24.4M | Buy |
|
|||||
|
2013
Q2 | $20.1M | Buy |
|